Chen et al. [40] reported that treatment with the irinotecan metabolite, SN-38, induced autophagy in LOVO and HCT116 colorectal cancer cell lines, as evidenced by LC3-II elevation as well as p62/SQSTM1 degradation, standard indicators of autophagy. This evidence concerns the gene SQSTM1 and colorectal cancer.